Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSirona Biochem Corp

Sirona Biochem Corp

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
None CAD 0.00(0%)
Last update at 2025-10-30T20:04:20.698353Z
Market Cap
15.53M

Momentum Score

…

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.05
Low
0.08
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
-0.02M
Revenue Per Share
-
Gross Profit TTM
-0.08M
Debt / Equity
-
ROE
-9810.47%
Net Debt
1.61M
ROCE
406.16%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Income before tax -3.55M -2.31M -4.14M -4.56M -1.15M
Net income -3.56M -2.31M -4.13M -4.55M -1.27M
Selling general administrative 2.67M 1.40M 2.96M 3.34M 1.28M
Gross profit - - - 0.14M 1.28M
Reconciled depreciation 0.01M 0.01M 0.01M - 0.00M
Ebit -3.39M -2.13M -4.00M -4.20M -0.86M
Ebitda -3.52M -2.30M -4.12M -4.44M -0.93M
Operating income -3.54M -2.30M -4.17M -4.47M -0.94M
Interest expense 0.03M 0.00M 0.01M 0.12M 0.23M
Tax provision 0.01M -0.01M -0.01M -0.01M 0.12M
Interest income - - 0.04M - -
Net interest income -0.03M -0.00M 0.03M -0.12M -0.23M
Income tax expense 0.01M -0.01M -0.01M -0.01M 0.12M
Total revenue 0.67M 0.27M 0.11M 0.14M 1.28M
Total operating expenses 4.21M 2.56M 4.28M 4.60M 2.22M
Cost of revenue - - - - 0.06M
Total other income expense net 0.01M -0.01M 0.00M 0.03M 0.02M
Net income from continuing ops -3.56M -2.31M -4.13M -4.55M -1.27M
Net income applicable to common shares -3.56M -2.31M -4.13M -4.55M -1.27M
Breakdown 2023-10-31 2022-10-31 2021-10-31 2020-10-31 2019-10-31
Type yearly yearly yearly yearly yearly
Date 2023-10-31 2022-10-31 2021-10-31 2020-10-31 2019-10-31
Total assets 1.03M 1.29M 1.29M 2.14M 4.26M
Total liab 3.54M 1.08M 1.38M 2.09M 2.07M
Total stockholder equity -2.51M 0.21M -0.10M 0.05M 2.19M
Other current liab - 0.18M 0.11M 0.11M 0.10M
Common stock - 34.49M 31.21M 29.08M 28.52M
Capital stock 34.66M 34.49M 31.21M 29.08M 28.52M
Retained earnings -43.90M -41.36M -37.80M -35.49M -31.36M
Other liab - 0.12M 0.13M 0.12M 0.10M
Cash 0.57M 0.42M 0.78M 1.54M 3.73M
Total current liabilities 1.87M 0.86M 0.74M 1.03M 0.92M
Net debt 1.61M 0.01M - - -
Short term debt - - - - 0.47M
Short long term debt 0.64M 0.34M 0.30M 0.26M 0.47M
Other stockholder equity - -0.22M -0.06M -0.10M -0.01M
Property plant equipment - 0.02M 0.03M 0.04M -
Total current assets 1.02M 1.27M 1.26M 2.10M 4.26M
Net tangible assets - 0.21M -0.10M 0.05M 2.19M
Short term investments - - - - 0.00M
Net receivables 0.01M 0.80M 0.44M 0.50M 0.46M
Long term debt 1.54M 0.09M 0.47M 0.85M 0.94M
Accounts payable 1.12M 0.32M 0.30M 0.62M 0.31M
Non currrent assets other - - - - 0.00M
Non current assets total 0.01M 0.02M 0.03M 0.04M 0.00M
Capital lease obligations 0.01M 0.04M 0.08M 0.13M 0.14M
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Investments - - -0.05M - 0.00M
Change to liabilities 0.09M -0.29M 0.41M 0.06M -0.02M
Total cashflows from investing activities - - -0.05M -0.05M -0.05M
Net borrowings -0.34M -0.31M -0.13M -0.24M -0.22M
Total cash from financing activities 2.04M 1.45M -0.05M 6.96M 0.66M
Change to operating activities -0.02M 0.05M 0.02M 0.09M -0.02M
Net income -3.56M -2.31M -4.13M -4.55M -1.27M
Change in cash -0.36M -0.76M -2.20M 3.40M 0.07M
Begin period cash flow 0.78M 1.54M 3.73M 0.34M 0.27M
End period cash flow 0.42M 0.78M 1.54M 3.73M 0.34M
Total cash from operating activities -2.18M -2.16M -2.11M -3.56M -0.59M
Issuance of capital stock - - 0.00M 3.14M 0.60M
Depreciation 0.01M 0.01M 0.01M 0.01M 0.01M
Change to account receivables -0.36M 0.05M -0.03M -0.15M 0.41M
Change to netincome 1.67M 0.34M 1.62M 0.99M 0.32M
Capital expenditures 0.00M 0.00M 0.05M 0.05M 0.05M
Change in working capital -0.30M -0.20M 0.39M 0.00M 0.36M
Stock based compensation 1.46M 0.33M 1.62M 1.06M -
Other non cash items 0.20M - 0.00M 0.03M 0.24M
Free cash flow -2.18M -2.16M -2.16M -3.56M -0.65M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SHRX
Sharp Therapeutics Corp.		 -
-%		 1.37 - - - 32.37 - -
NRX
NurExone Biologic Inc.		 -0.03
5.00%		 0.47 - 6.90 - 15.26 - -7.24
MIR
MedMira Inc		 -0.01
9.09%		 0.05 - - 223.37 - 293.42 -80.03
TTI
Thiogenesis Therapeutics Corp.		 -
-%		 0.63 - - - 15.17 - -58.16

Profile*

Sirona Biochem Corp

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

595 Burrard Street, Vancouver, BC, Canada, V7X 1L4

604 641 4466

https://www.sironabiochem.com

Name Title Year Born
Dr. Howard J. Verrico M.D., Ph.D. Founder, Chairman, CEO & Sec. 1961
Mr. Christopher D. Hopton C.G.A., C.P.A. CFO & Director 1966
Dr. Géraldine Deliencourt-Godefroy Ph.D. Chief Scientific Officer & Director NA
Ms. Michelle Seltenrich MBA VP of Operations NA
Dr. Brett A. Premack Ph.D. Scientific Consultant NA
Dr. Howard J. Verrico M.D., Ph.D. Founder, Chairman of the Board, CEO & Secretary 1961
Mr. Christopher D. Hopton C.G.A., CPA CFO & Director 1966

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.34
+14.45%
OMG
CAD 1.70
+13.76%
ARTG
CAD 39.54
+12.59%
DSV
CAD 10.83
+12.58%
TLRY
CAD 4.17
+12.10%
DRUG
CAD 25.95
-30.02%
HUT
CAD 69.16
-22.20%
UCU
CAD 2.04
-16.39%
PHX
CAD 10.70
-15.62%
VET
CAD 15.04
-13.31%

Equity Sectors*

  • Basic Materials

    +4.80%

  • Communication Services

    +2.78%

  • Consumer Cyclical

    +2.82%

  • Consumer Defensive

    +0.74%

  • Energy

    -4.92%

  • Financial Services

    +2.47%

  • Healthcare

    -0.30%

  • Industrials

    -0.38%

  • Real Estate

    +1.75%

  • Technology

    +0.82%

  • Utilities

    +1.29%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…